Andreas Rummelt, Director at ALEXION PHARMACEUTICALS INC (ALXN), bought 5,000 shares at $52.60 ($263K) on 2010-05-10, disclosed to the SEC on 2010-05-12.
Open-market purchase of $263k ALXN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ALXN | SELL | 2012-06-08 | $913K | — | Filing → |
| ALXN | SELL | 2012-02-23 | $537K | — | Filing → |
| ALXN | SELL | 2011-10-25 | $622K | — | Filing → |